{"entity":{"type":"insider","cik":"0001432241","url":"/insider/0001432241","json_url":"/insider/0001432241.json","name":"OrbiMed Capital GP III LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":265,"n_filings":56,"first":"2011-02-10","last":"2018-08-21","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP III LLC","source":"filing","n_filings":56,"first_seen":"2011-02-10","last_seen":"2018-08-21"}],"transactions":[{"id":9211129,"accession":"0000947871-18-000690","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-18-000690","line_url":"/filing/0000947871-18-000690","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307842.0,"shares_display":"307,842","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":3072263.16,"total_display":"3,072,263.16","total_whole":"3,072,263","shares_owned_after":7234976.0,"shares_owned_after_display":"7,234,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-21","scope":"insider","n_lines":2},{"id":6855819,"accession":"0000947871-18-000680","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-18-000680","line_url":"/filing/0000947871-18-000680","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155387.0,"shares_display":"155,387","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":1550762.26,"total_display":"1,550,762.26","total_whole":"1,550,762","shares_owned_after":7310457.0,"shares_owned_after_display":"7,310,457","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-20","scope":"insider","n_lines":2},{"id":9211130,"accession":"0000947871-18-000690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-18-000690","line_url":"/filing/0000947871-18-000690","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366220.0,"shares_display":"366,220","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":3640226.8,"total_display":"3,640,226.80","total_whole":"3,640,227","shares_owned_after":70364.0,"shares_owned_after_display":"70,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-21","scope":"insider","n_lines":2},{"id":6855812,"accession":"0000947871-18-000680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-18-000680","line_url":"/filing/0000947871-18-000680","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366220.0,"shares_display":"366,220","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":3640226.8,"total_display":"3,640,226.80","total_whole":"3,640,227","shares_owned_after":7464378.0,"shares_owned_after_display":"7,464,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-20","scope":"insider","n_lines":2},{"id":9211134,"accession":"0000947871-18-000691","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-18-000691","line_url":"/filing/0000947871-18-000691","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78050.0,"shares_display":"78,050","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":775036.5,"total_display":"775,036.50","total_whole":"775,037","shares_owned_after":73819.0,"shares_owned_after_display":"73,819","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-21","scope":"insider","n_lines":2},{"id":6570541,"accession":"0000947871-18-000672","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-18-000672","line_url":"/filing/0000947871-18-000672","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78050.0,"shares_display":"78,050","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":775036.5,"total_display":"775,036.50","total_whole":"775,037","shares_owned_after":7827143.0,"shares_owned_after_display":"7,827,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-15","scope":"insider","n_lines":2},{"id":9211136,"accession":"0000947871-18-000691","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-18-000691","line_url":"/filing/0000947871-18-000691","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20975.0,"shares_display":"20,975","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":208491.5,"total_display":"208,491.50","total_whole":"208,492","shares_owned_after":7828976.0,"shares_owned_after_display":"7,828,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-21","scope":"insider","n_lines":2},{"id":6570536,"accession":"0000947871-18-000672","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-18-000672","line_url":"/filing/0000947871-18-000672","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20975.0,"shares_display":"20,975","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":208491.5,"total_display":"208,491.50","total_whole":"208,492","shares_owned_after":7904457.0,"shares_owned_after_display":"7,904,457","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-15","scope":"insider","n_lines":2},{"id":9211135,"accession":"0000947871-18-000691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-18-000691","line_url":"/filing/0000947871-18-000691","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86923.0,"shares_display":"86,923","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":867491.54,"total_display":"867,491.54","total_whole":"867,492","shares_owned_after":7849753.0,"shares_owned_after_display":"7,849,753","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-21","scope":"insider","n_lines":2},{"id":6570529,"accession":"0000947871-18-000672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-18-000672","line_url":"/filing/0000947871-18-000672","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86923.0,"shares_display":"86,923","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":867491.54,"total_display":"867,491.54","total_whole":"867,492","shares_owned_after":7925234.0,"shares_owned_after_display":"7,925,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-15","scope":"insider","n_lines":2},{"id":6492709,"accession":"0000947871-18-000654","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000947871-18-000654","line_url":"/filing/0000947871-18-000654","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":684793.0,"shares_display":"684,793","price_per_share":9.96,"price_display":"9.96","price_state":"stated","total_value":6820538.28,"total_display":"6,820,538.28","total_whole":"6,820,538","shares_owned_after":7935856.0,"shares_owned_after_display":"7,935,856","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-10","scope":"insider","n_lines":2},{"id":6492705,"accession":"0000947871-18-000654","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000947871-18-000654","line_url":"/filing/0000947871-18-000654","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201343.0,"shares_display":"201,343","price_per_share":9.925253572262259,"price_display":"9.93","price_state":"stated","total_value":1998380.33,"total_display":"1,998,380.33","total_whole":"1,998,380","shares_owned_after":8640328.0,"shares_owned_after_display":"8,640,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-10","scope":"insider","n_lines":6},{"id":6492685,"accession":"0000947871-18-000654","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-18-000654","line_url":"/filing/0000947871-18-000654","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":482660.0,"shares_display":"482,660","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":4826600.0,"total_display":"4,826,600.00","total_whole":"4,826,600","shares_owned_after":8749057.0,"shares_owned_after_display":"8,749,057","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-10","scope":"insider","n_lines":2},{"id":6539321,"accession":"0000947871-18-000632","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-18-000632","line_url":"/filing/0000947871-18-000632","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50627.0,"shares_display":"50,627","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":506776.27,"total_display":"506,776.27","total_whole":"506,776","shares_owned_after":9201025.0,"shares_owned_after_display":"9,201,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-07","scope":"insider","n_lines":2},{"id":6539315,"accession":"0000947871-18-000632","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-18-000632","line_url":"/filing/0000947871-18-000632","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ViewRay, Inc.","issuer_ticker":"VRAY","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119293.0,"shares_display":"119,293","price_per_share":11.71,"price_display":"11.71","price_state":"stated","total_value":1396921.03,"total_display":"1,396,921.03","total_whole":"1,396,921","shares_owned_after":9251174.0,"shares_owned_after_display":"9,251,174","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-03","filed_date":"2018-08-07","scope":"insider","n_lines":2},{"id":6475021,"accession":"0000947871-18-000372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-18-000372","line_url":"/filing/0000947871-18-000372","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"PIERIS PHARMACEUTICALS, INC.","issuer_ticker":"PIRS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP III LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":6.35,"price_display":"6.35","price_state":"stated","total_value":6350000.0,"total_display":"6,350,000.00","total_whole":"6,350,000","shares_owned_after":4511130.0,"shares_owned_after_display":"4,511,130","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-30","filed_date":"2018-05-02","scope":"insider","n_lines":2},{"id":6012889,"accession":"0000947871-18-000220","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000947871-18-000220","line_url":"/filing/0000947871-18-000220","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"GLAUKOS Corp","issuer_ticker":"GKOS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161321.0,"shares_display":"161,321","price_per_share":30.704457696146193,"price_display":"30.70","price_state":"stated","total_value":4953273.82,"total_display":"4,953,273.82","total_whole":"4,953,274","shares_owned_after":66790.0,"shares_owned_after_display":"66,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-06","scope":"insider","n_lines":6},{"id":6012872,"accession":"0000947871-18-000220","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000947871-18-000220","line_url":"/filing/0000947871-18-000220","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"GLAUKOS Corp","issuer_ticker":"GKOS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210596.0,"shares_display":"210,596","price_per_share":32.43983095595358,"price_display":"32.44","price_state":"stated","total_value":6831698.64,"total_display":"6,831,698.64","total_whole":"6,831,699","shares_owned_after":240314.0,"shares_owned_after_display":"240,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider","n_lines":4},{"id":6012862,"accession":"0000947871-18-000220","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-18-000220","line_url":"/filing/0000947871-18-000220","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"GLAUKOS Corp","issuer_ticker":"GKOS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP III LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":464583.0,"shares_display":"464,583","price_per_share":32.29179561025694,"price_display":"32.29","price_state":"stated","total_value":15002219.28,"total_display":"15,002,219.28","total_whole":"15,002,219","shares_owned_after":562839.0,"shares_owned_after_display":"562,839","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-06","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":"2018-03-02|6012855","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597313","name":"ViewRay, Inc.","url":"/issuer/0001597313","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2016-08-24","last_seen":"2018-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001583648","name":"PIERIS PHARMACEUTICALS, INC.","url":"/issuer/0001583648","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2015-07-08","last_seen":"2018-05-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001192448","name":"GLAUKOS Corp","url":"/issuer/0001192448","role":"Director","n_filings":7,"first_seen":"2016-08-05","last_seen":"2018-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001472343","name":"Roka BioScience, Inc.","url":"/issuer/0001472343","role":"Ten percent owner","n_filings":6,"first_seen":"2014-07-24","last_seen":"2017-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001453687","name":"SELECTA BIOSCIENCES INC","url":"/issuer/0001453687","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2016-06-29","last_seen":"2016-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000806888","name":"RESPONSE BIOMEDICAL CORP","url":"/issuer/0000806888","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2013-11-12","last_seen":"2016-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001551693","name":"Sientra, Inc.","url":"/issuer/0001551693","role":"Ten percent owner","n_filings":5,"first_seen":"2015-09-28","last_seen":"2015-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001131543","name":"AMBIT BIOSCIENCES CORP","url":"/issuer/0001131543","role":"Ten percent owner","n_filings":2,"first_seen":"2013-05-22","last_seen":"2013-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000897448","name":"AMARIN CORP PLC\\UK","url":"/issuer/0000897448","role":"Director","n_filings":12,"first_seen":"2011-03-02","last_seen":"2012-09-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001361103","name":"COMPLETE GENOMICS INC","url":"/issuer/0001361103","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-13","last_seen":"2012-07-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira Pharmaceuticals, Inc.","url":"/issuer/0001396814","role":"Ten percent owner","n_filings":5,"first_seen":"2011-02-10","last_seen":"2012-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001368148","name":"ATHERSYS, INC / NEW","url":"/issuer/0001368148","role":"Ten percent owner","n_filings":1,"first_seen":"2011-04-29","last_seen":"2011-04-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001432241","retrieved_at":"2026-08-26T13:02:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}